PBX3 and colorectal carcinoma: In this study, we found that CRC patients with PBL PBX3 hypermethylation status had a better overall survival (OS) (hazard ratio [HRPS‐adjusted], 0.72 [95% CI, 0.52‐1.00]; P = 0.049).